209 related articles for article (PubMed ID: 23027872)
1. Conservation of functional sites on interleukin-6 and implications for evolution of signaling complex assembly and therapeutic intervention.
Veverka V; Baker T; Redpath NT; Carrington B; Muskett FW; Taylor RJ; Lawson AD; Henry AJ; Carr MD
J Biol Chem; 2012 Nov; 287(47):40043-50. PubMed ID: 23027872
[TBL] [Abstract][Full Text] [Related]
2. Novel Insights into Interleukin 6 (IL-6) Cis- and Trans-signaling Pathways by Differentially Manipulating the Assembly of the IL-6 Signaling Complex.
Lacroix M; Rousseau F; Guilhot F; Malinge P; Magistrelli G; Herren S; Jones SA; Jones GW; Scheller J; Lissilaa R; Kosco-Vilbois M; Johnson Z; Buatois V; Ferlin W
J Biol Chem; 2015 Nov; 290(45):26943-26953. PubMed ID: 26363066
[TBL] [Abstract][Full Text] [Related]
3. In vitro reconstitution of recognition and activation complexes between interleukin-6 and gp130.
Chow D; Ho J; Nguyen Pham TL; Rose-John S; Garcia KC
Biochemistry; 2001 Jun; 40(25):7593-603. PubMed ID: 11412113
[TBL] [Abstract][Full Text] [Related]
4. Reversal of some viral IL-6 electrostatic properties compared to IL-6 contributes to a loss of alpha receptor component recruitment.
Perret D; Rousseau F; Tran V; Gascan H
Proteins; 2005 Jul; 60(1):14-26. PubMed ID: 15861391
[TBL] [Abstract][Full Text] [Related]
5. Functional implications of large backbone amplitude motions of the glycoprotein 130-binding epitope of interleukin-6.
Bobby R; Robustelli P; Kralicek AV; Mobli M; King GF; Grötzinger J; Dingley AJ
FEBS J; 2014 May; 281(10):2471-83. PubMed ID: 24712547
[TBL] [Abstract][Full Text] [Related]
6. Discovery and characterization of a monoclonal antibody targeting a conformational epitope of IL-6/IL-6Rα to inhibit IL-6/ IL-6Rα/gp130 hexameric signaling complex formation.
Chou CC; Hua KT; Chen MW; Wu CJ; Hsu CH; Wang JT; Hsiao M; Wei LH
MAbs; 2022; 14(1):2029675. PubMed ID: 35133941
[TBL] [Abstract][Full Text] [Related]
7. Hexameric structure and assembly of the interleukin-6/IL-6 alpha-receptor/gp130 complex.
Boulanger MJ; Chow DC; Brevnova EE; Garcia KC
Science; 2003 Jun; 300(5628):2101-4. PubMed ID: 12829785
[TBL] [Abstract][Full Text] [Related]
8. Characterization of the Interleukin (IL)-6 Inhibitor IL-6-RFP: fused receptor domains act as high affinity cytokine-binding proteins.
Metz S; Wiesinger M; Vogt M; Lauks H; Schmalzing G; Heinrich PC; Müller-Newen G
J Biol Chem; 2007 Jan; 282(2):1238-48. PubMed ID: 17085445
[TBL] [Abstract][Full Text] [Related]
9. Molecular Dynamics Simulations Reveal Key Roles of the Interleukin-6 Alpha Receptor in the Assembly of the Human Interleukin-6 Receptor Complex.
Schillinger O; Panwalkar V; Strodel B; Dingley AJ
J Phys Chem B; 2017 Aug; 121(34):8113-8122. PubMed ID: 28783950
[TBL] [Abstract][Full Text] [Related]
10. Signaling conformations of the tall cytokine receptor gp130 when in complex with IL-6 and IL-6 receptor.
Skiniotis G; Boulanger MJ; Garcia KC; Walz T
Nat Struct Mol Biol; 2005 Jun; 12(6):545-51. PubMed ID: 15895091
[TBL] [Abstract][Full Text] [Related]
11. Complex N-linked glycans on Asn-89 of Kaposi sarcoma herpes virus-encoded interleukin-6 mediate optimal function by affecting cytokine protein conformation.
Dela Cruz CS; Viswanathan SR; El-Guindy AS; Shedd D; Miller G
J Biol Chem; 2009 Oct; 284(43):29269-82. PubMed ID: 19690161
[TBL] [Abstract][Full Text] [Related]
12. Structural requirements for gp80 independence of human herpesvirus 8 interleukin-6 (vIL-6) and evidence for gp80 stabilization of gp130 signaling complexes induced by vIL-6.
Chen D; Nicholas J
J Virol; 2006 Oct; 80(19):9811-21. PubMed ID: 16973585
[TBL] [Abstract][Full Text] [Related]
13. A fusion protein of the gp130 and interleukin-6Ralpha ligand-binding domains acts as a potent interleukin-6 inhibitor.
Ancey C; Küster A; Haan S; Herrmann A; Heinrich PC; Müller-Newen G
J Biol Chem; 2003 May; 278(19):16968-72. PubMed ID: 12646580
[TBL] [Abstract][Full Text] [Related]
14. Molecular characterization and expression analysis of the putative interleukin 6 receptor (IL-6Rα and glycoprotein-130) in rainbow trout (Oncorhynchus mykiss): salmonid IL-6Rα possesses a polymorphic N-terminal Ig domain with variable numbers of two repeats.
Costa MM; Wang T; Monte MM; Secombes CJ
Immunogenetics; 2012 Mar; 64(3):229-44. PubMed ID: 22033524
[TBL] [Abstract][Full Text] [Related]
15. Molecular dynamics analysis of the binding of human interleukin-6 with interleukin-6 α-receptor.
Gupta M; Ha K; Agarwal R; Quarles LD; Smith JC
Proteins; 2021 Feb; 89(2):163-173. PubMed ID: 32881084
[TBL] [Abstract][Full Text] [Related]
16. IL-6 controls the innate immune response against Listeria monocytogenes via classical IL-6 signaling.
Hoge J; Yan I; Jänner N; Schumacher V; Chalaris A; Steinmetz OM; Engel DR; Scheller J; Rose-John S; Mittrücker HW
J Immunol; 2013 Jan; 190(2):703-11. PubMed ID: 23241882
[TBL] [Abstract][Full Text] [Related]
17. Biophysical insight into protein-protein interactions in the Interleukin-11/Interleukin-11Rα/glycoprotein 130 signaling complex.
Mori C; Nagatoishi S; Matsunaga R; Kuroda D; Nakakido M; Tsumoto K
Biochem Biophys Res Commun; 2023 Nov; 682():174-179. PubMed ID: 37820452
[TBL] [Abstract][Full Text] [Related]
18. Structure-guided optimization of the interleukin-6 trans-signaling antagonist sgp130.
Tenhumberg S; Waetzig GH; Chalaris A; Rabe B; Seegert D; Scheller J; Rose-John S; Grötzinger J
J Biol Chem; 2008 Oct; 283(40):27200-7. PubMed ID: 18650419
[TBL] [Abstract][Full Text] [Related]
19. Interleukin-6 signaling requires EHD1-mediated alteration of membrane rafts.
Woo JH; Park SJ; Park SM; Joe EH; Jou I
FEBS J; 2022 Oct; 289(19):5914-5932. PubMed ID: 35429212
[TBL] [Abstract][Full Text] [Related]
20. Molecular mechanisms for viral mimicry of a human cytokine: activation of gp130 by HHV-8 interleukin-6.
Boulanger MJ; Chow DC; Brevnova E; Martick M; Sandford G; Nicholas J; Garcia KC
J Mol Biol; 2004 Jan; 335(2):641-54. PubMed ID: 14672670
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
